BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23184772)

  • 1. Inorganic nanoparticles based contrast agents for X-ray computed tomography.
    Jakhmola A; Anton N; Vandamme TF
    Adv Healthc Mater; 2012 Jul; 1(4):413-31. PubMed ID: 23184772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalization of inorganic nanoparticles for bioimaging applications.
    Erathodiyil N; Ying JY
    Acc Chem Res; 2011 Oct; 44(10):925-35. PubMed ID: 21648430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid BaYbF(5) nanoparticles: novel binary contrast agent for high-resolution in vivo X-ray computed tomography angiography.
    Liu Y; Ai K; Liu J; Yuan Q; He Y; Lu L
    Adv Healthc Mater; 2012 Jul; 1(4):461-6. PubMed ID: 23184777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents.
    Jackson PA; Rahman WN; Wong CJ; Ackerly T; Geso M
    Eur J Radiol; 2010 Jul; 75(1):104-9. PubMed ID: 19406594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications.
    Aviv H; Bartling S; Kieslling F; Margel S
    Biomaterials; 2009 Oct; 30(29):5610-6. PubMed ID: 19592085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications.
    Liu Y; Ai K; Lu L
    Acc Chem Res; 2012 Oct; 45(10):1817-27. PubMed ID: 22950890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-ε-caprolactone tungsten oxide nanoparticles as a contrast agent for X-ray computed tomography.
    Jakhmola A; Anton N; Anton H; Messaddeq N; Hallouard F; Klymchenko A; Mely Y; Vandamme TF
    Biomaterials; 2014 Mar; 35(9):2981-6. PubMed ID: 24393266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold nanoparticles as contrast agents in x-ray imaging and computed tomography.
    Cole LE; Ross RD; Tilley JM; Vargo-Gogola T; Roeder RK
    Nanomedicine (Lond); 2015 Jan; 10(2):321-41. PubMed ID: 25600973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-circulating Er3+-doped Yb2O3 up-conversion nanoparticle as an in vivo X-Ray CT imaging contrast agent.
    Liu Z; Li Z; Liu J; Gu S; Yuan Q; Ren J; Qu X
    Biomaterials; 2012 Oct; 33(28):6748-57. PubMed ID: 22770569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid-conjugated LaF3:Yb,Tm@SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography.
    Ma J; Huang P; He M; Pan L; Zhou Z; Feng L; Gao G; Cui D
    J Phys Chem B; 2012 Dec; 116(48):14062-70. PubMed ID: 23134318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
    Cheon J; Lee JH
    Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological performance of a size-fractionated core-shell tantalum oxide nanoparticle x-ray contrast agent.
    Torres AS; Bonitatibus PJ; Colborn RE; Goddard GD; FitzGerald PF; Lee BD; Marino ME
    Invest Radiol; 2012 Oct; 47(10):578-87. PubMed ID: 22836312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of inorganic nanomaterials in biomedical imaging.
    Li J; Chang X; Chen X; Gu Z; Zhao F; Chai Z; Zhao Y
    Biotechnol Adv; 2014; 32(4):727-43. PubMed ID: 24389087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and computed tomography imaging of a tantalum oxide nanoparticle imaging agent.
    Bonitatibus PJ; Torres AS; Goddard GD; FitzGerald PF; Kulkarni AM
    Chem Commun (Camb); 2010 Dec; 46(47):8956-8. PubMed ID: 20976321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric nanoparticles for molecular imaging.
    Srikar R; Upendran A; Kannan R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(3):245-67. PubMed ID: 24616442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid nanomaterials for biomedical applications.
    Taylor-Pashow KM; Della Rocca J; Huxford RC; Lin W
    Chem Commun (Camb); 2010 Aug; 46(32):5832-49. PubMed ID: 20623072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V.2. X-ray-based medical imaging: X-ray projection technique, image subtraction method, direct digital X-ray imaging, computed tomography (CT).
    Niederer PF
    Stud Health Technol Inform; 2010; 152():274-301. PubMed ID: 20407200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General approach for the synthesis of organic-inorganic hybrid nanoparticles mediated by supercritical CO2.
    Moisan S; Martinez V; Weisbecker P; Cansell F; Mecking S; Aymonier C
    J Am Chem Soc; 2007 Aug; 129(34):10602-6. PubMed ID: 17685528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic Nanoparticles for X-Ray Computed Tomography Imaging.
    Attia MF; Wallyn J; Anton N; Vandamme TF
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):391-431. PubMed ID: 30317944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.